NCT01848067: Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer |
|
|
| Completed | 1/2 | 9 | US | Alisertib, MLN8237, Abiraterone acetate, Abiraterone, Zytiga, Prednisone, Cortan, Deltasone, Orasone, Prednisone Intensol, Sterapred, Rayos | Sidney Kimmel Cancer Center at Thomas Jefferson University, Millennium: The Takeda Oncology Company | Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer | 03/15 | 06/16 | | |
